Hexamethonium is a peripherally-acting nondepolarizing neuromuscular blocking agent that acts as an antagonist of nicotinic acetylcholine receptors (nAChRs).
1,2 It decreases acetylcholine release induced by carbamoylcholine (Item No.
14486) in isolated cat superior cervical ganglion when used at concentrations of 27.4 and 54.8 μg/ml.
3 It also decreases mean arterial pressure in unanesthetized rats when administered at a dose of 40 mg/kg.
4 Intraventricular administration of hexamethonium (18 ng, i.c.v.) induces signs of nicotine abstinence, including shaking, writhing, and chewing in nicotine-dependent rats.
5 Formulations containing hexamethonium were previously used in the treatment of hypertension.